Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-12

Clinical Trial Update: Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma [NA]

View source ↗

Summary

A terminated clinical trial studied a preoperative combination of capecitabine, oxaliplatin, cetuximab, and radiation therapy for locally advanced esophageal ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Cetuximab (cetuximab)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Esophageal Adenocarcinoma | NA | Status: TERMINATED | Results posted: 2013-12-12